share_log

Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $225

Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $225

Keybanc维持对重症监护病房医疗的增持,将目标股价下调至225美元
Benzinga Real-time News ·  2022/08/09 04:34

Keybanc analyst Matthew Mishan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $230 to $225.

Keybanc分析师马修·米山维持ICU Medical(纳斯达克股票代码:ICUI)增持 “增持”,并将目标股价从230美元下调至225美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发